ALERT: Rosen Law Firm Reminds Sanofi Investors of Important February 2, 2015 Class Action Deadline - SNY

NEW YORK, Jan. 20, 2015 (GLOBE NEWSWIRE) -- The Rosen Law Firm, a global investor-rights firm, reminds purchasers of Sanofi securities SNY during the period from February 7, 2013 through December 3, 2014, of the important February 2, 2015 lead plaintiff deadline in the class action.

To join the Sanofi class action, go to the website http://www.rosenlegal.com/cases-455.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action.

"Disregarding truthful disclosure and fueled by corporate greed, the lawsuit claims, Sanofi engaged in an illegal scheme to funnel tens of millions of dollars in kickbacks and other incentives to get the Company's diabetes drugs prescribed and sold," said Rosen attorney Phillip Kim. As a result, the lawsuit asserts that the Sanofi's public statements were materially false and misleading at all relevant times. "This looks to be another instance of a large company attempting to profit from its misdeeds at the expense of their investors," added Kim.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

If you wish to join the class action go to http://www.rosenlegal.com/cases-455.html or to discuss your rights or interests regarding this class action, please contact, Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com.

The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.